Experience in the Management of Pancreatic Adenocarcinoma with Whipple Procedure at the Institute of Social Security and Services for State Workers of Puebla

Authors

  • Cristian Jair Flores González Department of Surgery, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Miguel Ángel Alonso Blanco Department of Surgery, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Edgar Grageda Flores Department of Surgery, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Carlos Alberto López Bernal Department of Surgery, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Norma Rojas Bernal Department of Pathology, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Georgina Loyola Rodriguez Department of Pathology, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Jorge Rojas Gonzalez Department of Radiology, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Mónica Patricia Hernández Molina Department of Surgical Oncology, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México
  • Diomedes Jesus Durango Hernandez Department of Surgery, Hospital de Especialidades “5 de mayo”, ISSSTEP, Puebla city, México https://orcid.org/0009-0005-2946-9755

DOI:

https://doi.org/10.14738/bjhr.1203.18825

Abstract

Background: Currently, in the management of periampullary tumors, pancreatic carcinoma is the most frequent, considered a tumor with a poor prognosis. Approximately 95% of cases are exocrine cell tumors, most commonly pancreatic ductal adenocarcinomas (PDAC). According to INEGI, in Mexico, PDAC is the twelfth leading cause of cancer, with 4,489 cases diagnosed annually, accounting for 4.9% of oncological deaths. Methods: A retrospective descriptive observational study was designed for patients managed with pancreaticoduodenectomy during 2023 and 2024, at a tertiary care center in Puebla, Mexico. Results: A total of 16 patients went to surgery, with malignancy reported in 13 of them. A predominance of female-to-male ratio greater than 2:1 was observed, and the complication rate was 81%, with respiratory complications predominating, followed by biliopancreatic fistula. Conclusions: The Whipple procedure is considered a high-complexity surgery with a high risk of complications. However, in selected cases, it is the treatment of choice for periampullary tumors, showing better survival, especially in the early stages of pancreatic cancer.

References

Grossberg, A. J., Chu, L. C., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., Weekes, C. D., & Thomas, C. R., Jr (2020). Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA: a cancer journal for clinicians, 70(5), 375–403. https://doi.org/10.3322/caac.21626

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed.

Tintelnot, J., Xu, Y., Lesker, T. R., Schönlein, M., Konczalla, L., Giannou, A. D., Pelczar, P., Kylies, D., Puelles, V. G., Bielecka, A. A., Peschka, M., Cortesi, F., Riecken, K., Jung, M., Amend, L., Bröring, T. S., Trajkovic-Arsic, M., Siveke, J. T., Renné, T., Zhang, D., … Gagliani, N. (2023). Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature, 615(7950), 168–174. https://doi.org/10.1038/s41586-023-05728-y

D'Cruz JR, Misra S, Menon G, et al. Pancreaticoduodenectomy (Whipple Procedure) [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560747/

Sherko Abdullah Molah Karim, Karzan Seerwan Abdulla, Qalandar Hussein Abdulkarim, Fattah Hama Rahim, The outcomes and complications of pancreaticoduodenectomy (Whipple procedure): Cross sectional study, International Journal of Surgery, Volume 52,2018, Pages 383-387, ISSN 1743-9191, https://doi.org/10.1016/j.ijsu.2018.01.041.

Beger, H. G., Friess, H., & Uhl, W. (2023). Whipple Resection for Benign Tumors and Premalignant Neoplasms of the Pancreatic Head: Surgery-Associated Risk for Complications and Late Metabolic Morbidity Matters. Annals of surgery open: perspectives of surgical history, education, and clinical approaches, 4(3), e325. https://doi.org/10.1097/AS9.0000000000000325

Beger H. G. (2024). Prämaligne, zystische Neoplasien und neuroendokrine Tumoren des Pankreaskopfes –Ist die Kausch-Whipple-Resektion eine adäquate Therapie? [Premalignant cystic neoplasms and neuroendocrine tumors of the pancreatic head-Is the Kausch-Whipple resection an adequate treatment?]. Chirurgie (Heidelberg, Germany), 95(6), 461–465. https://doi.org/10.1007/s00104-024-02070-5

Russell, T. B., & Aroori, S. (2022). Procedure-specific morbidity of pancreatoduodenectomy: a systematic review of incidence and risk factors. ANZ journal of surgery, 92(6), 1347–1355. https://doi.org/10.1111/ans.17473D. J. (2025). Experience in the Management of Pancreatic Adenocarcinoma with Whipple Procedure at the Institute of Social Security and Services

Torres, O. J., Vasques, R. R., & Torres, C. C. (2016). THE OBITUARY OF THE PYLORUS-PRESERVING PANCREATODUODENECTOMY. Arquivos brasileiros de cirurgia digestiva: ABCD = Brazilian archives of digestive surgery, 29(2), 71–72. https://doi.org/10.1590/0102-6720201600020001

Takada T. (1993). Pylorus-preserving pancreatoduodenectomy: technique and indications. Hepatogastroenterology, 40(5), 422–425.

Yamaguchi, K., Kishinaka, M., Nagai, E., Nakano, K., Ohtsuka, T., Chijiwa, K., & Tanaka, M. (2001). Pancreatoduodenectomy for pancreatic head carcinoma with or without pylorus preservation. Hepatogastroenterology, 48(41), 1479–1485.

Heise, J. W., Becker, H., Borchard, F., & Röher, H. D. (1994). Zum Radikalitätsrisiko der pyloruserhaltenden Duodenopankreatektomie beim duktalen Carcinom [Risks of radical treatment in pylorus preserving duodenopancreatectomy in ductal carcinoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 65(9), 780–784.

Stefan W. Leichtle, Christodoulos Kaoutzanis, Nicolas J. Mouawad, Kathleen B. Welch, Richard Lampman, Verne L. Hoshal, Edward Kreske, Classic Whipple versus pylorus-preserving pancreaticoduodenectomy in the ACS NSQIP, Journal of Surgical Research, Volume 183, Issue 1,2013, Pages 170-176,ISSN 0022-4804, https://doi.org/10.1016/j.jss.2013.01.016.

Giorgio Romano, Antonino Agrusa, Massimo Galia, Giuseppe Di Buono, Daniela Chianetta, Vincenzo Sorce, Leonardo Gulotta, Giuseppe Brancatelli, Gaspare Gulotta, Whipple’s pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center, International Journal of Surgery, Volume 21, Supplement 1, 2015, Pages S68-S71, ISSN 1743-9191, https://doi.org/10.1016/j.ijsu.2015.06.062.

Melloul, E., Lassen, K., Roulin, D., Grass, F., Perinel, J., Adham, M., Wellge, E. B., Kunzler, F., Besselink, M. G., Asbun, H., Scott, M. J., Dejong, C. H. C., Vrochides, D., Aloia, T., Izbicki, J. R., & Demartines, N. (2020). Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019. World journal of surgery, 44(7), 2056–2084. https://doi.org/10.1007/s00268-020-05462-w

Araujo, R. L., Karkar, A. M., Allen, P. J., Gönen, M., Chou, J. F., Brennan, M. F., Blumgart, L. H., D'Angelica, M. I., DeMatteo, R. P., Coit, D. G., Fong, Y., & Jarnagin, W. R. (2014). Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. HPB: the official journal of the International Hepato Pancreato Biliary Association, 16(3), 250–262. https://doi.org/10.1111/hpb.12107

Carlos Fernández-del Castillo, Vicente Morales-Oyarvide, Deborah McGrath, Jennifer A. Wargo, Cristina R. Ferrone, Sarah P. Thayer, Keith D. Lillemoe, Andrew L. Warshaw, Evolution of the Whipple procedure at the Massachusetts General Hospital, Surgery, Volume 152, Issue 3, Supplement, 2012, Pages S56-S63, ISSN 0039-6060, https://doi.org/10.1016/j.surg.2012.05.022.

Park W, Chawla A, O’Reilly EM. Pancreatic Cancer: A Review. JAMA. 2021;326(9):851–862. doi:10.1001/jama.2021.13027

Poddighe D. Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations. World J Gastroenterol 2021; 27(25): 3825-3836 [PMID: 34321847 DOI: 10.3748/wjg.v27.i25.3825

Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., & Neoptolemos, J. P. (2016). Pancreatic cancer. Nature reviews. Disease primers, 2, 16022. https://doi.org/10.1038/nrdp.2016.22

Ballehaninna, U. K., & Chamberlain, R. S. (2011). Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian journal of surgical oncology, 2(2), 88–100. https://doi.org/10.1007/s13193-011-0042-1

McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018). Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World journal of gastroenterology, 24(43), 4846–4861. https://doi.org/10.3748/wjg.v24.i43.4846

Downloads

Published

2025-06-25

How to Cite

González, C. J. F., Blanco, M. Ángel A., Flores, E. G., Bernal, C. A. L., Bernal, N. R., Rodriguez, G. L., … Durango Hernandez, D. J. (2025). Experience in the Management of Pancreatic Adenocarcinoma with Whipple Procedure at the Institute of Social Security and Services for State Workers of Puebla. British Journal of Healthcare and Medical Research, 12(03), 405–415. https://doi.org/10.14738/bjhr.1203.18825